NasdaqCM - Nasdaq Real Time Price
USD
Citius Oncology, Inc. (CTOR)
0.5540
+0.0245
(+4.63%)
At close: October 30 at 4:00:01 PM EDT
0.5536
-0.0004
(-0.07%)
After hours: October 30 at 5:35:12 PM EDT
Earnings Trends
Earnings Per Share (GAAP)
Revenue vs. Earnings
Q2 FY26
Revenue
1.67M
Earnings
-26.61M
Profit Margin
-1,595.98%
Q3
FY25
Q4
FY25
Q1
FY26
Q2
FY26
-20M
-10M
0
-1500.0%
-1000.0%
-500.0%
0.0%
Revenue Estimate
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
1 | 1 | 1 | 1 |
|
Avg. Estimate
|
3.29M | 14.27M | 10.39M | 47.58M |
|
Low Estimate
|
3.29M | 14.27M | 10.39M | 47.58M |
|
High Estimate
|
3.29M | 14.27M | 10.39M | 47.58M |
|
Year Ago Sales
|
-- | 3.94M | -- | 10.39M |
|
Sales Growth (year/est)
|
0.00% | 261.88% | 0.00% | 357.83% |
Earnings Estimate
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
-- | -- | -- | -- |
|
Avg. Estimate
|
-- | -- | -- | -- |
|
Low Estimate
|
-- | -- | -- | -- |
|
High Estimate
|
-- | -- | -- | -- |
|
Year Ago EPS
|
-- | -- | -- | -- |
Earnings History
EPS Trend
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Current Estimate
|
-- | -- | -- | -- |
|
7 Days Ago
|
-- | -- | -- | -- |
|
30 Days Ago
|
-- | -- | -- | -- |
|
60 Days Ago
|
-- | -- | -- | -- |
|
90 Days Ago
|
-- | -- | -- | -- |
EPS Revisions
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Up Last 7 Days
|
-- | -- | -- | -- |
|
Up Last 30 Days
|
-- | -- | -- | -- |
|
Down Last 7 Days
|
-- | -- | -- | -- |
|
Down Last 30 Days
|
-- | -- | -- | -- |
Growth Estimates
| Symbol | Current Qtr. | Next Qtr. | Current Year | Next Year |
|---|---|---|---|---|
|
CTOR
|
-- | -- | -- | -- |
|
S&P 500
|
26.99% | 26.80% | 32.87% | 16.85% |
